Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 versus standard care for superficial partial-thickness burn wounds
2012-000362-38Phase 3Completed
- Sponsor
- Birken AG
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Birch bark extract in burn injury and superficial partial-thickness burn (2 arms), sponsored by Birken AG. Primary endpoint: Earlier healing of Oleogel-S10-treated wound half. Started Apr 2012; status: completed.
02
Drugs
Birch bark extract
03
Conditions
burn injurysuperficial partial-thickness burn
Beyond the preview
Go deeper on 2012-000362-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000362-38.